2nd Circ. OKs $5M Deal In Telik Cancer Drug Suit
A federal appeals court has brushed aside a challenge from a disgruntled shareholder who claims biopharmaceutical company Telik Inc. got off too easily with a $5 million class action settlement after...To view the full article, register now.
Already a subscriber? Click here to view full article